Myriad Genetics Inc (NASDAQ:MYGN)
| 19.10 Delayed Data As of 3:59pm ET |  -0.14 / -0.73%Today’s Change | 13.82 Today|||52-Week Range 24.21 | +31.63% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Assets | Cash | 110.9M | 93.3M | 90.6M | 84.9M | |
| Short Term Investment Cash | 13.5M | -17.6M | -2.7M | -5.7M | ||
| Cash & Short Term Investments | 180.6M | 167.5M | 165.4M | 149.7M | ||
| Receivables | Receivables | 102.1M | 123.4M | 122.5M | 147.0M | |
| Inventories | Inventories | 34.3M | 35.9M | 33.3M | 31.9M | |
| Current Assets | Prepaid Expenses | 9.4M | 15.1M | 15.6M | 14.3M | |
| Current Assets | 326.4M | 341.9M | 336.8M | 342.9M | ||
| Total Assets | Property, Plant and Equipment - Gross | 157.1M | 164.5M | 165.4M | 167.8M | |
| Depreciation | -113.9M | -104.5M | -106.3M | -109.1M | ||
| Intangible Assets | 773.8M | 1.1B | 1.1B | 1.1B | ||
| Other Assets | 773.8M | 1.1B | 1.1B | 1.1B | ||
| Total Assets | 1.2B | 1.6B | 1.6B | 1.6B | ||
| Liabilities | Accounts Payable | 26.0M | 23.8M | 31.9M | 24.1M | |
| Accrued Expenses | 14.5M | 18.8M | 17.7M | 21.6M | ||
| Other Current Liabilities | 22.4M | 26.6M | 25.4M | 27.6M | ||
| Other Liabilities | 102.2M | 108.0M | 113.3M | 108.9M | ||
| Total Liabilities | Long Term Debt | 9.3M | 258.0M | 273.3M | 263.4M | |
| Deferred Taxes | -57.3M | -64.9M | -88.9M | -85.7M | ||
| Other Liabilities | 300.0K | 9.8M | 10.9M | 11.5M | ||
| Total Liabilities | 261.4M | 471.4M | 492.5M | 475.6M | ||
| Equity | Minority Interest | 0.00 | -100.0K | 0.00 | 0.00 | |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 964.9M | 1.1B | 1.1B | 1.1B | ||
| Total Shareholder Equity | 964.9M | 1.1B | 1.1B | 1.1B | ||
| Share Information | Common Shares Outstanding | 70.6M | 74.7M | 73.2M | 73.4M | |
| Addtl. Info. | No data currently available for this section. | |||||
